From: Smartphones in the secondary prevention of cardiovascular disease: a systematic review
Worringham, 2011 | Forman, 2014 | Varnfield, 2011 | Blasco, 2012 | Varnfield, 2014 | |
---|---|---|---|---|---|
Country of Origin | Australia | USA | Australia | Spain | Australia |
Levels of evidence | |||||
Design | FUU | FUU | FUU | RCT | RCT |
Level of Evidence* | IV | IV | IV | II | II |
CASP score | n/a | n/a | n/a | 7 | 8 |
Theoretical framework | ✓ | ✓ | |||
Outcome measures | |||||
Technology | |||||
 Feasibility | ✓ | ✓ | ✓ | ✓ | |
 Usability | ✓ | ✓ | ✓ | ||
 Technical problems | ✓ | ✓ | ✓ | ||
 Acceptability | ✓ | ✓ | ✓ | ✓ | |
 Engagement | ✓ | ✓ | |||
 Adherence | ✓ | ✓ | ✓ | ✓ | ✓ |
 Usage | ✓ | ||||
 Task completion | ✓ | ||||
Patient | |||||
Uptake | ✓ | ✓ | ✓ | ||
PROs | ✓ | ||||
Program completion | ✓ | ✓ | |||
Qualitative feedback | ✓ | ✓ | ✓ | ||
CV risk improvement | ✓ | ||||
Physical activity | ✓ | ✓ | ✓ | ||
Step counter | ✓ | ✓ | |||
6MWT | ✓ | ✓ | |||
Nutrition | ✓ | ✓ | ✓ | ||
Smoking status | ✓ | ||||
Psychological distress | ✓ | ||||
Depression | ✓ | ✓ | |||
Anxiety | ✓ | ✓ | |||
QOL | ✓ | ✓ | ✓ | ||
Self-efficacy | |||||
BP and HR | ✓ | ✓ | ✓ | ||
Weight | ✓ | ✓ | |||
BMI | ✓ | ✓ | |||
Waist circumference | ✓ | ||||
HbA1c | ✓ | ✓ | |||
Plasma lipid level | ✓ | ✓ | |||
PVO2 | |||||
Medication adherence | |||||
Economic evaluation | ✓ |